Knight Therapeutics (GUD.TO)

Moved out of this to increase his position in another holding. This company has great leadership and great management. He is just waiting for them to execute on a deal. They are all cashed up and waiting for something to happen.

In this one, the stock price is way ahead of itself. Sitting on a lot of cash. There is no cash flow or earnings, so there is nothing to analyze at this point. Thinks it is way too early for this story. Would prefer Concordia Healthcare (CXR-T) and BioSyent (RX-X).

You have to accept that there has been quite a significant market correction in lots of stocks. The key thing with this one is that you have the brilliant backdrop of Jonathan Good who knows what he is doing. There is a voucher that the FDA has granted the company that is worth $200 million possibly, to advance the process. You have to be patient. The company just has to really get started.

Paladin labs management team. They have one product that has received approval. It is way too early to gauge the fundamentals of the company. It could be a 6-10 year story. You have to stick with them or the volatility will make you lose sleep at night.

Manager has an amazing track record for creating value. He is recovering from a bad bike accident a couple of years ago. They are moving to the TSX. This should give the stock a boost.

Moving from Venture to TSX. This means the company is growing, which is a good thing. If they get included in the broad index them more analysts cover it and so a potential for broader ownership. Basically this move is a good thing.

Got hit today because they are issuing warrants. Good opportunity to buy in right now. Has a lot of cash. Very interesting fundamental story. Technically it looks very strong as well.

Only on the market a couple of months. There are only two people in the company. A drug has just been approved. Thinks it will be very exciting.